⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IPHA News
Innate Pharma S.A. ADS
Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight
globenewswire.com
IMVT
ROIV
MRK
NVS
REGN
UCB
JNJ
ARGX
AMGN
VIR
IPHA
ARWR
APLS
CABA
A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company
prnewswire.com
GTBP
IPHA
INKT
IPSC
Synovial Sarcoma Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
KURA
BMY
IPHA
MRK
MNPR
JAZZ
MOLN
LLY
GSK
AGEN
PFE
Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
SNGX
IPHA
BMY
NKTX
AZN
MRK
TAK
NVS
GMAB
ABBV
BIIB
CRSP
INCY
ALKS
PFE
REGN
GILD
AMGN
Innate Pharma to participate in the Jefferies Global Healthcare Conference
businesswire.com
IPHA
Innate Pharma participera à la conférence Jefferies Global Healthcare
businesswire.com
IPHA
B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters Clinic
prnewswire.com
IPHA
GTBP
GSK
SMMT
IDYA
Tetraspecific Antibodies Clinical Pipeline Market research 2026: Development Technologies, Therapeutic Approaches & Market Opportunity Insight to 2032
globenewswire.com
OPK
IPHA
Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 16 avril 2026
businesswire.com
IPHA
Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026
businesswire.com
IPHA